Ron Andrews recently joined Life Technologies as President of Medical Sciences. His main focus will be to transition the molecular discoveries from the life science research area into molecular diagnostic applications to improve patient care in the era of personalized medicine. Prior to joining Life, Ron was Founder & CEO of Clarient Inc., which began in 2004 as a Molecular Pathology Service organization delivering “academic level” molecular testing services to community pathologists and oncologists. From 2002 Ron was SVP Global Marketing & Commercial BD at Pleasanton, CA-based Roche Molecular Diagnostics. Ron developed and led the strategic execution for all diagnostic commercial operations including team oversight of global marketing and BD in blood screening, virology, women’s health, microbiology and automation/emerging diagnostics. He was also responsible for executive direction of all marketing functions, oversaw the development of the company’s 10-year Strategic Plan, and completed the reorganization of commercial operations. From 2000 to 2002 Ron held two senior positions at Roche Diagnostics. As VP, U.S. Commercial Operations, Molecular Diagnostics, he directed sales, marketing, technical field support, and product development activities and was responsible for US commercial strategy development for the clinical lab market. Prior to that, as VP, Marketing, US Commercial Operations, he was responsible for planning and directing all aspects of the US Lab Systems Commercial Operations Marketing. From 1995 to 2000, Ron was VP of Immucor, Inc. where he helped lead its transition from a reagent manufacturer to an instrument systems company. Prior to Immucor, he spent almost 10 years in management positions at Abbott Diagnostics, culminating as Sr. Marketing Manager, Business Unit Operations. Ron earned a Bachelor’s degree in Biology and Chemistry from Wofford College in 1981 and has participated in the executive development programs at Roche and Abbott Labs.